Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Follow-Up Questions
¿Quién es el CEO de Alpha Teknova Inc?
Mr. Stephen Gunstream es el President de Alpha Teknova Inc, se unió a la empresa desde 2019.
¿Qué tal es el rendimiento del precio de la acción TKNO?
El precio actual de TKNO es de $5.11, ha decreased un 0.37% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Alpha Teknova Inc?
Alpha Teknova Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Alpha Teknova Inc?
La capitalización bursátil actual de Alpha Teknova Inc es $273.5M
¿Es Alpha Teknova Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para Alpha Teknova Inc, incluyendo 4 fuerte compra, 5 compra, 3 mantener, 0 venta, y 4 fuerte venta
